Recombinant multi-species ADAM9 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ADAM9 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The protein encoded by this gene interacts with SH3 domain-containing proteins, binds mitotic arrest deficient 2 beta protein, and is also involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. Several alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Jul 2010]
The Alternative Names of target: ADAM 9,ADAM9,Adam9,CORD9,Cellular disintegrin-related protein,Disintegrin and metalloproteinase domain-containing protein 9,MCMP,MDC9,Meltrin-gamma,Metalloprotease/disintegrin/cysteine-rich protein 9,Mltng,Myeloma cell metalloproteinase,mKIAA0021

Target products collectionGo to ADAM9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T03672-Ag-1/ GM-Tg-hg-T03672-Ag-2 Human ADAM9 protein Human
GM-Tg-rg-T03672-Ag-1/ GM-Tg-rg-T03672-Ag-2 Rat ADAM9 protein Rat
GM-Tg-mg-T03672-Ag-1/ GM-Tg-mg-T03672-Ag-2 Mouse ADAM9 protein Mouse
GM-Tg-cynog-T03672-Ag-1/ GM-Tg-cynog-T03672-Ag-2 Cynomolgus/Rhesus macaque ADAM9 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T03672-Ag-1/ GM-Tg-felg-T03672-Ag-2 Feline ADAM9 protein Feline
GM-Tg-cang-T03672-Ag-1/ GM-Tg-cang-T03672-Ag-2 Canine ADAM9 protein Canine
GM-Tg-bovg-T03672-Ag-1/ GM-Tg-bovg-T03672-Ag-2 Bovine ADAM9 protein Bovine
GM-Tg-equg-T03672-Ag-1/ GM-Tg-equg-T03672-Ag-2 Equine ADAM9 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T03672-Ag-1/ GM-Tg-hg-T03672-Ag-2; GM-Tg-rg-T03672-Ag-1/ GM-Tg-rg-T03672-Ag-2;
GM-Tg-mg-T03672-Ag-1/ GM-Tg-mg-T03672-Ag-2; GM-Tg-cynog-T03672-Ag-1/ GM-Tg-cynog-T03672-Ag-2;
GM-Tg-felg-T03672-Ag-1/ GM-Tg-felg-T03672-Ag-2; GM-Tg-cang-T03672-Ag-1/ GM-Tg-cang-T03672-Ag-2;
GM-Tg-bovg-T03672-Ag-1/ GM-Tg-bovg-T03672-Ag-2; GM-Tg-equg-T03672-Ag-1/ GM-Tg-equg-T03672-Ag-2
Products Name ADAM9 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ADAM9
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ADAM9 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.